In a broad comparison among healthy women and each clinical stage of BC patients, RNase P levels were different in the controls and BC patients in stage I (p < 0.01), whereas PUM1 levels were lower in controls than in BC patients in stages I–III (Figure 3). This evidence concerns the gene PUM1 and breast cancer.